Grifols: Positive/Neutral Scenario Posits An Upside
Source: SeekingAlpha
2025-12-08 12:02:09 ET
I've been a frequent analyst for covering Grifols, S.A. ( GRFS ) as a business here on Seeking Alpha. The world's largest blood plasma business, with other adjacent/related businesses, is going through a renaissance, rising like a phoenix from the ashes of what was once an immensely troubled business on the verge of being sold....
Read the full article on Seeking Alpha
For further details see:
Grifols: Positive/Neutral Scenario Posits An Upside
Takeda Pharmaceutical Company Limited American Depositary Shares
NASDAQ: TAK
TAK Trading
-1.63% G/L:
$17.82 Last:
1,287,637 Volume:
$17.90 Open:
TAK Latest News
March 02, 2026 02:00:00 am
Takeda and Protagonist Announce U.S. Food and Drug Administration Accepts New Drug Application and Grants Priority Review for Rusfertide as a Potential First-in-Class Therapy for Polycythemia Vera
February 24, 2026 09:35:00 am
Next-Generation Psychiatric Therapies Target Massive $40B+ Market Opportunity
TAK Stock Data
$57,107,745,653
3,115,826,299
N/A
157
N/A
Pharmaceuticals
Healthcare
JP
Chuo-ku
